Ammonul Medicis - Treatment for Urea Cycle Disorder

Ammonul is a combination of 10% sodium phenylacetate and 10% sodium benzoate indicated as an adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.

Posted: February 2005

Ammonul (sodium benzoate and sodium phenylacetate) FDA Approval History

View comments

Hide
(web5)